A method for preparing microcapsules using metal organic coordination polymer as wall material
By performing coordination reaction between metal ions and phenolic organic ligands at the oil-water interface of the microemulsion, metal organic coordination polymer microcapsules were prepared, and the problem of water solubility limitation of metal ions-tannin acid in the prior art is solved. It achieves efficient drug packaging and slow-controlled release, and has good industrial application.
Patent Information
- Application Number
- CN202110979623.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2021-08-25
- Publication Date
- 2024-11-12
- Estimated Expiration
- 2041-08-25
AI Technical Summary
The prior art is difficult to prepare microcapsules using the coordination supramolecular system of metal ion-tannin acid. It is mainly because its water-soluble characteristics limit the application scope of the interfacial polymerization method, resulting in the lack of abundant microcapsule preparation materials.
Through the microemulsion as a template, metal ions and phenolic organic ligands undergo coordination reaction at the oil-water interface of the microemulsion to form a metal ion-phenolic coordination polymer film, and use oil-in-water and water-in-oil microemulsions to form an oil-in-water and water-in-oil microemulsions. Different methods were used to prepare microcapsules, realizing self-assembly of metal-organic coordination polymers.
It realizes the preparation of separation membranes with high separation selectivity, simple process and easy operation, can encapsulate water-soluble and oil-soluble drugs, achieve slow-controlled release of drugs, and the materials are cheap and non-toxic, and have good industrial practicality.
Smart Images

Figure QLYQS_1 
Figure BDA0003228556710000021 
Figure HDA0003228556720000011
Abstract
Description
Technical Field
[0001] The present invention belongs to the technical fields of biomedical engineering, pharmaceutical carrier and membrane engineering, and relates to a microcapsule and a preparation method thereof, and in particular to a microcapsule using a metal organic coordination polymer as a wall material and a preparation method thereof. Background Art
[0002] Microcapsule technology is a technology that uses film-forming materials to embed solids, liquids or gases into tiny capsules with diameters ranging from tens of nanometers to thousands of micrometers. The encapsulated material is called the core material, and the material that encapsulates the core material is called the wall material. Since microcapsules have good protection for the core material, slow release, controlled release, shape change, and masking of bad odors, microcapsule technology has been widely used in many fields such as food, medicine, dyes, cosmetics, pesticides, and fertilizers.
[0003] In recent years, the coordination supramolecular system based on metal ion-tannic acid has attracted wide attention due to its rapid coordination reaction and pH responsiveness, which is a very ideal microcapsule wall material, for example, CN110622965A. However, due to the water solubility of metal ions and tannic acid, it is difficult to prepare microcapsules using interfacial polymerization, which greatly limits its application range. Therefore, it is still necessary to explore new coordination systems to enrich the preparation materials of microcapsules. Summary of the invention
[0004] In order to solve the technical problems existing in the background technology, the present invention provides a method for preparing microcapsules using metal organic coordination polymers as wall materials.
[0005] The present invention is specifically achieved through the following technical solutions:
[0006] The microemulsion is used as a template to make the metal ions and the phenolic organic ligands undergo coordination reaction at the oil-water interface of the microemulsion to obtain the microcapsule.
[0007] The size of the microcapsules obtained by the method is about 10 to 300 μm.
[0008] The microemulsion is an oil-in-water emulsion or a water-in-oil emulsion.
[0009] The microemulsion is in the form of droplet encapsulation, which is oil-in-water droplets or water-in-oil droplets, so that the oil-water interface of the microemulsion is spherical.
[0010] The microcapsule preparation method is slightly different according to the different methods used for oil-in-water type and water-in-oil type needle microemulsion.
[0011] For the oil-in-water microemulsion, an aqueous solution containing a metal salt with a concentration of 0.1 to 100 mM is slowly added to the oil-in-water microemulsion to react at the spherical oil-water interface to form a metal ion-phenol coordination polymer membrane, which is then washed, filtered and collected to obtain microcapsules encapsulating oil-soluble drugs.
[0012] The oil-in-water microemulsion is formed by stirring, vortexing or ultrasonicating an aqueous solution containing a hydrophilic emulsifier at a concentration of 0 to 10 wt% and an oil phase solution containing a phenolic organic ligand at a concentration of 0.1 to 30 mM, a specific drug and an organic solvent, and the volume of the aqueous phase: the volume of the oil phase = 1.5:1 to 20:1.
[0013] For oil-in-water microemulsion, an oil phase solution consisting of phenolic organic ligands and organic solvents with a concentration of 0.1 to 30 mM is added to the oil-in-water microemulsion, and a metal ion-phenol coordination polymer membrane is formed at the spherical oil-water interface. The membrane is then washed, filtered and collected to obtain microcapsules encapsulating water-soluble drugs.
[0014] The water-in-oil microemulsion is formed by mixing an oil phase solution containing a 0-10wt% lipophilic emulsifier with an aqueous phase solution containing a 0.1-30mM metal salt, a specific drug and water by stirring, vortexing or ultrasound, and the volume of the aqueous phase: the volume of the oil phase = 1:1.5-1:20.
[0015] The hydrophilic emulsifier is one or more of polyvinyl alcohol (PVA), polyvinyl pyrrolidone, sodium lauryl sulfate, Tween 20, Tween 80, and Triton 100.
[0016] Preferably, the lipophilic emulsifier is one or more of Span 80 and Span 20.
[0017] The phenolic organic ligand is one or two of the following molecular structures:
[0018]
[0019] Wherein A is one of -CHO and -CH=N-OH.
[0020] The metal salt is silver nitrate, anhydrous copper chloride, various hydrated copper chlorides, anhydrous copper sulfate, various hydrated copper sulfates, anhydrous copper nitrates, various hydrated copper nitrates, copper trifluoromethanesulfonate, anhydrous copper acetate, various hydrated copper acetates, copper bromide, anhydrous nickel chloride, various hydrated nickel chlorides, anhydrous nickel sulfate, various hydrated nickel sulfates, anhydrous nickel nitrates, various hydrated nickel nitrates, nickel trifluoromethanesulfonate, anhydrous nickel acetate, various hydrated nickel acetates, nickel bromide, anhydrous zinc chloride, various hydrated zinc chlorides, anhydrous zinc sulfate, various hydrated zinc sulfates, anhydrous zinc nitrates, various hydrated zinc nitrates, zinc trifluoromethanesulfonate, anhydrous zinc acetate, various hydrated zinc acetates, zinc bromide, anhydrous manganese chloride, various hydrated manganese chlorides, anhydrous manganese sulfate, various hydrated manganese sulfates, anhydrous manganese nitrates, various hydrated manganese nitrates, manganese trifluoromethanesulfonate, anhydrous manganese acetate, various hydrated manganese acetates, manganese bromide, anhydrous One or more of cobalt chloride, various hydrated cobalt chlorides, anhydrous cobalt sulfate, various hydrated cobalt sulfates, anhydrous cobalt nitrate, various hydrated cobalt nitrates, cobalt trifluoromethanesulfonate, anhydrous cobalt acetate, various hydrated cobalt acetates, cobalt bromide, anhydrous scandium chloride, various hydrated scandium chlorides, anhydrous scandium sulfate, various hydrated scandium sulfates, scandium trifluoromethanesulfonate, anhydrous scandium nitrate, various hydrated scandium nitrates, anhydrous ferric chloride, various hydrated ferric chlorides, scandium bromide, anhydrous ferric sulfate, various hydrated ferric sulfates, anhydrous ferric acetate, various hydrated ferric acetates, ferric bromide, anhydrous ferric sulfate, various hydrated ferric sulfates, ferric trifluoromethanesulfonate, titanium tetrachloride, zirconium tetrachloride, platinum chloride, chromium chloride, various hydrated chromium chlorides, chromium bromide, various hydrated chromium bromides, chromium sulfate, various hydrated chromium sulfates, anhydrous chromium nitrate, various hydrated chromium nitrates, chromium chloride, various hydrated chromium chlorides, chromium sulfate, and various hydrated chromium sulfates.
[0021] The organic solvent is one or more of oleic acid, ethanol, ethyl acetate, methyl acetate, toluene, o-xylene, mesitylene, dichloromethane, chloroform, dimethyl carbonate, n-hexane, n-heptane, n-pentane, methyl tert-butyl ether, n-butyl ether, isobutyl ether, n-hexanol, and ISOPAR series solvents.
[0022] The drugs include vitamin A, insulin, essence, niacinamide, etc., but are not limited thereto.
[0023] The microcapsule preparation method uses microemulsion as a template to cause metal ions and phenolic organic ligands to undergo coordination reaction at the oil-water interface to form a coordination polymer membrane, which is then washed, filtered and collected to obtain microcapsules encapsulating drugs.
[0024] Beneficial effects of the present invention:
[0025] Compared with the prior art, the present invention prepares a separation membrane with high separation selectivity through interface coordination self-assembly technology; the preparation is simple, the operation is easy, and the membrane has good industrial practicability.
[0026] The present invention adopts an emulsion interfacial reaction method to prepare microcapsules, which has a simple process and strong universality. It can encapsulate both water-soluble drugs and oil-soluble drugs, realize the controlled release of drugs, and improve their utilization efficiency. Moreover, the metal-phenol microcapsule material itself is inexpensive and has no obvious toxic effects. BRIEF DESCRIPTION OF THE DRAWINGS
[0027] Figure 1 This is a microscope image of the microcapsules obtained in Example 1. DETAILED DESCRIPTION
[0028] The present invention will be further described below in conjunction with the accompanying drawings and specific implementations.
[0029] Embodiments of the present invention are as follows:
[0030] Example 1
[0031] 1wt% PVA aqueous solution and 5mM trialdehyde pyrogallol o-xylene solution were stirred and mixed at a ratio of 5:1 to form an oil-in-water emulsion. Then, a certain amount of 5mM FeCl3 solution was slowly added while continuing to stir to induce a coordination reaction at the oil-water interface of the microemulsion to form a coordination polymer film. After stabilization for 3 minutes, stirring was stopped and the microcapsules were obtained by washing and filtration.
[0032] Example 2
[0033] 1wt% Span 80 dichloromethane solution and 2mM FeCl3 solution were mixed evenly at a ratio of 5:1 by magnetic stirring to form an oil-in-water emulsion. Then, a certain amount of 5mM trialdehyde pyrogallol dichloromethane solution was slowly added under continued stirring to induce a coordination reaction at the oil-water interface of the microemulsion to form a coordination polymer film. After stabilization for 3 minutes, stirring was stopped and the microcapsules were obtained by washing and filtration.
[0034] Example 3
[0035] A 1wt% Tween 20 aqueous solution and a 2mM trialdehyde pyrogallol oleic acid solution were stirred and mixed in a ratio of 3:1 to form an oil-in-water emulsion. Then, a certain amount of 1mM FeCl3 solution was slowly added while continuing to stir to induce a coordination reaction at the oil-water interface of the microemulsion to form a coordination polymer film. After stabilization for 3 minutes, stirring was stopped and the microcapsules were washed and filtered to obtain microcapsules.
[0036] Example 4
[0037] 0.5wt% Span 80 n-butyl ether solution and 2mM Fe(NO3)3 solution were stirred and mixed at a ratio of 10:1 to form an oil-in-water emulsion. Then, a certain amount of 5mM 2,4,6-trihydroxybenzene-1,3,5-benzenetricarbaldehyde oxime n-butyl ether solution was slowly added while continuing to stir to induce a coordination reaction at the oil-water interface of the microemulsion to form a coordination polymer film. After stabilization for 5 minutes, stirring was stopped and the microcapsules were obtained by washing and filtration.
[0038] Example 5
[0039] A 5wt% PVA aqueous solution and a 2mM trialdehyde pyrogallol oleic acid solution were stirred and mixed in a ratio of 5:1 to form an oil-in-water emulsion. Then, a certain amount of 1mM CuCl2 solution was slowly added while continuing to stir to induce a coordination reaction at the oil-water interface of the microemulsion to form a coordination polymer film. After stabilization for 3 minutes, stirring was stopped and the microcapsules were obtained by washing and filtration.
[0040] Example 6
[0041] A 2wt% PVA aqueous solution and an oleic acid solution containing 3mM trialdehyde phloroglucinol and vitamin A were stirred and mixed at a ratio of 4:1 to form an oil-in-water emulsion. Then, a certain amount of 1mM CuCl2 solution was slowly added under continued stirring to induce a coordination reaction at the oil-water interface of the microemulsion to form a coordination polymer film. After stabilization for 3 minutes, stirring was stopped and the microcapsules were washed and filtered to obtain microcapsules, such as Figure 1 shown.
[0042] Example 7
[0043] The oleic acid solution of 0.5wt% Span 80 and the aqueous solution containing 2mM FeCl3 and insulin drug were mixed evenly with magnetic stirring at a ratio of 5:1 to form an oil-in-water emulsion. Then, a certain amount of 5mM trialdehyde phloroglucinol dichloromethane solution was slowly added under continued stirring to induce a coordination reaction at the oil-water interface of the microemulsion to form a coordination polymer film. After stabilization for 3 minutes, stirring was stopped and the microcapsules were washed and filtered to obtain microcapsules, such as Figure 1 shown.
Claims
1. A method for preparing microcapsules using metal organic coordination polymers as wall materials, characterized in that: Using the microemulsion as a template, the metal ions and the phenolic organic ligands undergo coordination reaction at the oil-water interface of the microemulsion to obtain the microcapsules; The phenolic organic ligand is one or two of the following molecular structures: wherein A is one of -CHO and -CH=N-OH; 2. The method for preparing microcapsules using metal organic coordination polymers as wall materials according to claim 1, characterized in that: The microemulsion is an oil-in-water emulsion or a water-in-oil emulsion.
3. A method for preparing microcapsules using a metal organic coordination polymer as a wall material as claimed in claim 1 or 2, characterized in that: For the oil-in-water microemulsion, an aqueous solution containing a metal salt with a concentration of 0.1 to 100 mM is added to the oil-in-water microemulsion, and a metal ion-phenol coordination polymer membrane is formed at the oil-water interface, which is then washed, filtered and collected to obtain microcapsules encapsulating oil-soluble drugs.
4. A method for preparing microcapsules using metal organic coordination polymers as wall materials as claimed in claim 3, characterized in that: The oil-in-water microemulsion is formed by stirring, vortexing or ultrasonicating an aqueous solution containing a hydrophilic emulsifier at a concentration of 0 to 10 wt% and an oil phase solution containing a phenolic organic ligand at a concentration of 0.1 to 30 mM, a drug and an organic solvent, and the volume of the aqueous phase: the volume of the oil phase = 1.5:1 to 20:
1.
5. A method for preparing microcapsules using a metal organic coordination polymer as a wall material as claimed in claim 1 or 2, characterized in that: For the water-in-oil microemulsion, an oil phase solution consisting of a phenolic organic ligand and an organic solvent with a concentration of 0.1 to 30 mM is added to the water-in-oil microemulsion, and a metal ion-phenol coordination polymer membrane is formed at the oil-water interface. The membrane is then washed, filtered and collected to obtain microcapsules encapsulating water-soluble drugs.
6. A method for preparing microcapsules using metal organic coordination polymers as wall materials as claimed in claim 5, characterized in that: The water-in-oil microemulsion is formed by mixing an oil phase solution containing a lipophilic emulsifier at a concentration of 0 to 10 wt% with an aqueous phase solution containing a metal salt, a drug and water at a concentration of 0.1 to 30 mM by stirring, vortexing or ultrasound, and the volume of the aqueous phase: the volume of the oil phase = 1:1.5 to 1:
20.
7. The method for preparing microcapsules using metal organic coordination polymer as wall material as claimed in claim 4, characterized in that: The hydrophilic emulsifier is one or more of polyvinyl alcohol (PVA), polyvinyl pyrrolidone, sodium lauryl sulfate, Tween 20, Tween 80, and Triton 100.
8. A method for preparing microcapsules using a metal organic coordination polymer as a wall material as claimed in claim 3 or 6, characterized in that: The metal salt is silver nitrate, anhydrous copper chloride, various hydrated copper chlorides, anhydrous copper sulfate, various hydrated copper sulfates, anhydrous copper nitrates, various hydrated copper nitrates, copper trifluoromethanesulfonate, anhydrous copper acetate, various hydrated copper acetates, copper bromide, anhydrous nickel chloride, various hydrated nickel chlorides, anhydrous nickel sulfate, various hydrated nickel sulfates, anhydrous nickel nitrates, various hydrated nickel nitrates, nickel trifluoromethanesulfonate, anhydrous nickel acetate, various hydrated nickel acetates, nickel bromide, anhydrous zinc chloride, various hydrated zinc chlorides, anhydrous zinc sulfate, various hydrated zinc sulfates, anhydrous zinc nitrates, various hydrated zinc nitrates, zinc trifluoromethanesulfonate, anhydrous zinc acetate, various hydrated zinc acetates, zinc bromide, anhydrous manganese chloride, various hydrated manganese chlorides, anhydrous manganese sulfate, various hydrated manganese sulfates, anhydrous manganese nitrates, various hydrated manganese nitrates, manganese trifluoromethanesulfonate, One or more of anhydrous manganese acetate, various hydrated manganese acetates, manganese bromide, anhydrous cobalt chloride, various hydrated cobalt chlorides, anhydrous cobalt sulfate, various hydrated cobalt sulfates, anhydrous cobalt nitrate, various hydrated cobalt nitrates, cobalt trifluoromethanesulfonate, anhydrous cobalt acetate, various hydrated cobalt acetates, cobalt bromide, anhydrous scandium chloride, various hydrated scandium chlorides, anhydrous scandium sulfate, various hydrated scandium sulfates, scandium trifluoromethanesulfonate, anhydrous scandium nitrate, various hydrated scandium nitrates, anhydrous ferric chloride, various hydrated ferric chlorides, scandium bromide, anhydrous ferric sulfate, various hydrated ferric sulfates, anhydrous ferric acetate, various hydrated ferric acetates, ferric bromide, ferric trifluoromethanesulfonate, titanium tetrachloride, zirconium tetrachloride, platinum chloride, chromium chloride, various hydrated chromium chlorides, chromium bromide, various hydrated chromium bromides, chromium sulfate, various hydrated chromium sulfates, anhydrous chromium nitrate, and various hydrated chromium nitrates.
9. A method for preparing microcapsules using a metal organic coordination polymer as a wall material as claimed in claim 4 or 5, characterized in that: The organic solvent is one or more of oleic acid, ethanol, ethyl acetate, methyl acetate, toluene, o-xylene, mesitylene, dichloromethane, chloroform, dimethyl carbonate, n-hexane, n-heptane, n-pentane, methyl tert-butyl ether, n-butyl ether, isobutyl ether, n-hexanol, and ISOPAR series solvents.
